Article

Lymph node evaluation as a colon cancer quality measure: a national hospital report card.

Cancer Programs, American College of Surgeons, Chicago, IL 60611, USA.
CancerSpectrum Knowledge Environment (Impact Factor: 14.07). 09/2008; 100(18):1310-7. DOI: 10.1093/jnci/djn293
Source: PubMed

ABSTRACT Examination of 12 or more regional lymph nodes for colon cancer is associated with improved staging and survival, and the National Quality Forum recently endorsed lymph node examination for colon cancer as a quality surveillance measure. However, information regarding the extent of hospital compliance with the 12-node measure in the United States is lacking.
From the National Cancer Data Base, 1296 hospitals that performed 156 789 colectomies in 1996-1997 and 2004-2005 were identified, and rates of hospital-level compliance (defined as examination of >or=12 nodes in >or=75% of patients) in these two time periods were compared. Multivariable models were developed to determine if hospital type, volume, or differences in case mix were associated with 12-node measure compliance. All statistical tests were two-sided.
In 1996-1997, 15% of hospitals were compliant with the 12-node measure; in 2004-2005 the percentage of compliant hospitals had increased to 38%. From 1996-1997 to 2004-2005, 12-node measure compliance increased at 980 hospitals, remained unchanged at 6 hospitals, and decreased at 310 hospitals. In 2004-2005, National Cancer Institute-designated Comprehensive Cancer Centers were more frequently compliant with the 12-node measure than other academic hospitals, Veterans' Administration hospitals, or community hospitals (78.1% versus 52.4%, 53.1%, and 33.7%, respectively, all P < .001), even after adjustment for differences in characteristics of the colon cancer patients at these hospitals.
This study provides a national report card of nearly 1300 hospitals showing that more than 60% of institutions failed to achieve a compliance benchmark for the 12-node measure. Considerable improvement is needed in colon cancer nodal evaluation in the United States.

0 Bookmarks
 · 
90 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background and Objectives The aim of study was to assess time trends in the association between the total number of lymph nodes examined (TNLE) and survival in patients operated for adenocarcinoma of the head of pancreas.Methods Patients operated for node-negative adenocarcinoma of the head of pancreas between 1988 and 2007 were identified from the Surveillance, Epidemiology and End Results (SEER) database. Patients diagnosed between 1988 and 2002 were compared to those diagnosed between 2003 and 2007.ResultsA total of 3,406 patients were included. Although TNLE was associated with survival, the effect was not uniform. Compared to patients with >12 TNLE, survival decreased with lower TNLE (4–12 TNLE: hazard ratio [HR] 1.27, 95% CI 1.10–1.46; <4 TNLE: HR 1.39, 95% CI 1.20–1.60) among patients diagnosed between 1988 and 2002. In contrast, for those diagnosed between 2003 and 2007, while there was decreased survival for those with <4 nodes (HR 1.44, 95% CI 1.22–1.71), no effect was seen for patients with TNLE 4–12 (HR 0.98, 95% CI 0.85–1.14).Conclusion The prognostic significance of the TNLE in patients operated for adenocarcinoma of the head of the pancreas is not constant over time. J. Surg. Oncol. © 2014 Wiley Periodicals, Inc.
    Journal of Surgical Oncology 06/2014; 110(7). DOI:10.1002/jso.23715 · 2.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Within the field of oncology, increasing access to high quality care has been identified as a priority to reduce cancer disparities. Previous research reveals that the facilities where patients receive their cancer care have implications for cancer outcomes. However, there is little understanding of how patients decide where to seek cancer care. This study examined the factors that shape patients' pathways to seek their cancer care at a National Cancer Institute-designated comprehensive cancer center (NCI-CCC), and differences in these factors by race, income and education.
    PLoS ONE 10/2014; 9(10):e110649. DOI:10.1371/journal.pone.0110649 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the last 25 years, the treatment for rectal cancer has improved markedly. Multimodality therapy and higher-quality surgery have resulted in low rates of local recurrence (previously a terrible problem) as well as impressive rates of long-term survival that sometimes exceed those for colon cancer.1 Credit must be given to the important treatment trials and to the quality assessment and improvement programs in Europe and elsewhere that have raised the bar of care quality for rectal cancer.2 Thus it is appropriate that we turn our attention to preserving function and quality of life for these patients.Rectal cancer is indeed a condition for which treatment may result in extreme long-term effects on patient’s lives. Bowel function, sexual and urinary function, body image, and work and social productivity all are potentially affected for patients rendered cancer free.3,4 An oncologic success may be a quality-of-life failure.In this Annals of Surgical Oncology issue, Mohammed and colleagu ...
    Annals of Surgical Oncology 09/2014; 22(1). DOI:10.1245/s10434-014-4104-9 · 3.94 Impact Factor

Full-text (2 Sources)

Download
11 Downloads
Available from
Aug 4, 2014